The overexpressed SMYD3 transcriptionally up-regulated the expression of IGF-1R, through which the AKT/mTOR pathway was activated in BC cells, while the AKT downstream effector E2F1 further enhanced SMYD3 transcription. This evidence concerns the gene E2F1 and breast cancer.